Abstract
Epigenetic modifications, such as DNA methylation and histone acetylation, are well established as important players in tumourigenesis and thereby sought after targets in therapeutic intervention. Recent years have seen an increase in the research and clinical development of histone deacetylase (HDAC) inhibitors as anti-cancer agents, but emerging evidence now suggests that the class of enzymes performing the reciprocal function of histone acetylation, histone acetyltransferases (HATs), may also have pivotal roles in cancer progression. Here we discuss the role of HAT complexes in tumourigenesis and their potential as bona fide druggable cancer targets, focusing in particular on the evolutionary conserved TIP60 complex.
Keywords: Acetylation, cancer, epigenetics, HAT inhibitors, histone acetyltransferases, MRGBP, TIP60, tumour therapy.
Drug Delivery Letters
Title:Tipping the Balance Between Life and Death: Targeting Histone Acetylation for Cancer Therapy
Volume: 3 Issue: 2
Author(s): Stephen A. Watt and Andrew P. South
Affiliation:
Keywords: Acetylation, cancer, epigenetics, HAT inhibitors, histone acetyltransferases, MRGBP, TIP60, tumour therapy.
Abstract: Epigenetic modifications, such as DNA methylation and histone acetylation, are well established as important players in tumourigenesis and thereby sought after targets in therapeutic intervention. Recent years have seen an increase in the research and clinical development of histone deacetylase (HDAC) inhibitors as anti-cancer agents, but emerging evidence now suggests that the class of enzymes performing the reciprocal function of histone acetylation, histone acetyltransferases (HATs), may also have pivotal roles in cancer progression. Here we discuss the role of HAT complexes in tumourigenesis and their potential as bona fide druggable cancer targets, focusing in particular on the evolutionary conserved TIP60 complex.
Export Options
About this article
Cite this article as:
Watt A. Stephen and South P. Andrew, Tipping the Balance Between Life and Death: Targeting Histone Acetylation for Cancer Therapy, Drug Delivery Letters 2013; 3 (2) . https://dx.doi.org/10.2174/2210303111303020007
DOI https://dx.doi.org/10.2174/2210303111303020007 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
Current Topics in Medicinal Chemistry Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Platelet-derived Growth Factor Receptor (PDGFR) Kinase Inhibitors
Current Drug Metabolism Structural Modifications of Matrine-Type Alkaloids
Mini-Reviews in Medicinal Chemistry Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage
CNS & Neurological Disorders - Drug Targets Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
Current Medicinal Chemistry Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine
Current Radiopharmaceuticals Systemic Delivery of Curcumin: 21st Century Solutions for an Ancient Conundrum
Current Drug Discovery Technologies Subject Index To Volume 6
Current Topics in Medicinal Chemistry Technetium-99m-based Radiopharmaceuticals in Sentinel Lymph Node Biopsy: Gynecologic Oncology Perspective
Current Pharmaceutical Design Influence of Vanin-1 and Catalytic Products in Liver During Normal and Oxidative Stress Conditions
Current Medicinal Chemistry Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets Polymeric Drug Delivery Approaches for Colon Targeting: A Review
Drug Delivery Letters Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Rational Design of Non-Hydroxamate Histone Deacetylase Inhibitors
Mini-Reviews in Medicinal Chemistry Modification of Decoy Oligodeoxynucleotides to Achieve the Stability and Therapeutic Efficacy
Current Topics in Medicinal Chemistry Plant Natural Products in Anticancer Drug Discovery
Current Organic Chemistry Design and Synthesis of 4-substituted Quinazolines as Potent EGFR Inhibitors with Anti-breast Cancer Activity
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective Effects of Ellagitannins: A Brief Review
Current Drug Targets TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Protein & Peptide Letters The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets